USPTO serial 77306317
Serial No. 77306317
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CROWLEY, PAUL
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 77306317?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New Brunswick, NJ
New Brunswick, NJ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jake D. Feldman
JAKE D. FELDMAN JOHNSON & JOHNSONONE JOHNSON & JOHNSON PLAZANEW BRUNSWICK, NJ 08933-7001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | effervescent denture cleanser; toothpaste; skin soap; cold cream; all purpose cotton swabs for personal use; lip balm | ACTIVE | — |
| 005 | A full line of pharmaceuticals, namely, therapeutic ophthalmic preparations; eye drops; laxatives; antacids for the treatment of gastrointestinal disorders; antacid mints; antidiarrheal preparations; pharmaceutical preparations for the treatment of diarrhea, constipation, and abdominal discomfort; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for human use being gastric fluid inhibitors; pharmaceutical preparation for the alleviation of ulcers, treatment and alleviation of heartburn and other gastro-intestinal disorders; antiseptic mouthwash; denture adhesive cream; antiseptic throat lozenges; antiseptic for personal hygiene; anti-plaque mouth rinse; dental plaque remover; medicated personal cleansers, namely, hand sanitizing and disinfectant preparation with anti-bacterial and anti-microbial properties; medical compound in the form of medicated ointments and creams for treatment of wounds, skin abrasions, bruises, chapped skin, bedsores, sore feet, burns, scalds, sunburns, wind bite, diaper rash and rectal irritation for use in dermatology and pediatrics; mixture of antibiotics comprising single preparations for use in the treatment of general and local bacterial and virus infections; pharmaceutical preparations for treating dermatosis; medicated skin lotion for the relief of itch caused by insect bites, eczema, sunburn and poison ivy; mixture of antibiotics comprising single preparations for use in the treatment of general and local bacterial and virus infections; medicated lip balm for treatment of cold sores and dry or chapped lips; pharmaceutical preparation, namely, a topical dermatological for treatment of alopecia; vitamins; adhesive bandages; pharmaceutical preparation for temporary relief of nasal congestion; pharmaceutical preparations containing diphenhydramine hydrochloride for the relief of hay fever symptoms, itching skin, hives, motion sickness, cough, and sleeping difficulty; sinus headache treatment preparations in the nature of tablets; sinus medication; pharmaceutical preparations for use in the treatment of upper respiratory conditions; medicinal preparation for use as a sympathomimetic cough medication, decongestant and antihistamine; allergy and sinus medications; air freshener; refills for air fresheners; analgesic and antispasmodic preparation for relief of menstrual discomfort; pain relief medication, namely, pain relieving adhesive skin patches; sleeping medication for the treatment of insomnia; medicated cough and throat drops; analgesics; anti-inflammatory pharmaceutical preparations; analgesic preparations for the treatment of headaches, backaches, back pain, menstrual pain, and muscle pain; pharmaceutical preparations for the treatment of urological conditions and overactive bladder; pharmaceutical preparations, namely, dimenhydrinate tablets for the prevention and treatment of motion sickness, nausea and vomiting; pharmaceutical preparations, namely, an histamine antagonist for the treatment of allergies and ulcers; liquid dietary fiber composition for the treatment of gastro-intestinal disorders; pharmaceutical preparations, namely, miconazole nitrate antimicrobial cream; pharmaceutical preparations, namely, an anti-allergic solution for the prevention and treatment of allergic rhinitis; pediatric cold preparations | ACTIVE | — |
| 016 | facial tissues | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 18, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 18, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 14, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 22, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 19, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 19, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 19, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 19, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 18, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jun 18, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2007 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Oct 22, 2007 | NWAP | NEW APPLICATION ENTERED | — |